Universities around America are focusing their research on cannabis projects

Several universities in America have a common mission: to study and research the properties of cannabis through the creation of varied projects. The intention is to promote natural medicine as an alternative to treat different physical and mental diseases, such as chronic pain and obsessive disorders, among others.

Below, there is a list of a number of universities all around the American continent and the respective cannabis projects that are making a name for themselves in the international scientific community. Their studies are pushing forward cannabis and looking into new breakthroughs that will help clinical patients around the world.

If you want to know more about cannabis, how a considerable number of universities are focusing their research project on this medical plant, and to find out the latest cannabis news, download the Hemp.im mobile application.

Universities in Latin America are breaking paradigms and looking into new ways to treat epilepsy

The University of Buenos Aires (UBA) will start growing cannabis through its Cannabis Sativa project. The program’s director, Catalina van Baren, said it will be a small, scientific and experimental crop, according to the THC Cultura Cannábica website.

The philosophy of the UBA regarding this project is based on the fact that in order to study cannabis it is necessary to have the raw material, so its own cultivation is indispensable.

What does the project consist of? Through strains high in CBD, an experimental alternative to be used in the treatment of refractory epilepsy will be investigated, with the help of the Institute of Chemistry and Drug Metabolism (Iquimefa), an institution created by the University of Buenos Aires and Conicet. Cannabis Sativa began more than a year ago, although it was recently approved by the Ministry of Health.

On the other hand, members of the Center for Research and Advanced Studies (Cinevstav) of the National Polytechnic Institute (IPN) of Mexico are working on a project that will also investigate the therapeutic use of cannabinoids for the treatment of epilepsy, a neurological disease that affects more than two million Mexicans.

Cinevstav’s main concern is that people suffering from epilepsy tend to be stigmatized and segregated both socially and occupationally. They are currently analyzing the use of cannabidiol, one of the 600 components found in cannabis, for possible use in certain cases of epilepsy.

In North America, universities also take a step forward into cannabis-focused researches

The University of Mississippi (UM) diverse research includes studies of the botanical, pharmacological and chemical properties of cannabis. The university is known, among other things, for supporting the research community through its participation in the National Institute on Drug Abuse (NIDA) Drug Delivery Program.

One of its main projects focuses on CBD treatments to combat pediatric epilepsy. Researchers at the University of Mississippi Medical Center (UMMC) will conduct a pilot clinical trial to test the effects of a standardized CBD extract in treating seizures in children.

Finally, the University of New Mexico, a public research university located in Albuquerque and internationally recognized for its studies, created a project to study the impact of medical cannabis on people with chronic, debilitating health conditions.

The study focuses on people with PTSD, cancer, chronic pain, to name a few, and compares the outcomes of patients who use cannabis to those who use drugs, including narcotics. The project also examines how cannabis use affects central aspects of mental, physical, and social well-being, such as experiences of pain, sleep quality and eating behaviors.

The university also has a fund called the Medical Cannabis Research Fund (MCRF), which supports scientific research on medical cannabis in all areas of the social and biomedical sciences.

__

(Featured image by TinaKru via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Nacion Cannabis, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.